Safety of Stem Cell – Derived Therapies: Trends and Future Technologies – 7-8 October 2019

Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies

LifeArc monetises Keytruda® (pembrolizumab) royalty interests to fund further research and investment

Opening of Little France Park

Edinburgh & Lothians Greenspace Trust (ELGT) enlisted the help of local school children to help officially open the new active travel route through Little France Park.

Proteus

Hugely innovative in shortening the distance from bench to bedside, the QMRI-based Proteus project’s work is revolutionising the ways lung diseases are diagnosed and managed.

Centre for Cardiovascular Science

The Centre for Cardiovascular Science (CVS) is engaged in world-leading research into cardiovascular diseases. Co-located with the Royal Infirmary of Edinburgh and the University of Edinburgh’s…

CALCIVIS

Founded in 2012 by CEO Adam Christie and CTO Bruce Vernon, CALCIVIS has recently overseen the UK launch of its revolutionary dental imaging technology.

Aquila BioMedical

Beginning life as a University of Edinburgh start-up, Aquila BioMedical’s expertise in immunology, immuno-oncology and specialist histology supports a range of clients to discover their best…

Public partners reach campus-wide agreement for Edinburgh BioQuarter

The five-year collaboration agreement sees the City of Edinburgh Council joining NHS Lothian, Scottish Enterprise and the University of Edinburgh as official partners at the health…